QGEN Financials Qiagen N.V.

15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Oct 16, 2026, 10:06 UTC Overview →

Growth & profitability

Revenue has grown 2.2% per year over the past 5 years.
Net income has grown faster than revenue (3.4% vs 2.2% per year).
Operating margin has expanded, at 22.3% in the latest year.
Free cash flow has grown 6.9% per year over the past 5 years.

Financial health

Total debt ($1.7B) exceeds cash ($839M); net debt is $815M.
Total debt has grown slower than revenue (-3.0% vs 2.2% per year).
Operating income covered interest expense 14× in the latest year.
Total debt is 2.5× EBITDA.

Shareholder returns

Dividends have been paid for 1 consecutive year, consuming 12.8% of earnings and 12.0% of free cash flow.

Revenue & net income

RevenueNet income

Margins (gross / operating / net)

GrossOperatingNet

Return on equity & assets (ROE / ROA)

ROEROA

Free cash flow (CFO − capex)

Free cash flow

Cash vs total debt

CashTotal debt

Cash flow: operating / investing / financing

OperatingInvestingFinancing

Key annual figures

FY	Revenue	Net income	Gross M	Op M	ROE	ROA	FCF	Total debt	Cash
2025	$2.1B	$425M	62.2%	22.3%	11.2%	6.8%	$453M	$1.7B	$839M
2024	$2.0B	$84M	48.9%	4.9%	2.3%	1.5%	$506M	$1.4B	$664M
2023	$2.0B	$341M	62.8%	20.9%	9.0%	5.6%	$310M	$1.5B	$668M
2022	$2.1B	$423M	64.7%	24.8%	12.2%	6.7%	$586M	$1.9B	$731M
2021	$2.3B	$513M	64.4%	28.0%	16.6%	8.3%	$449M	$1.9B	$881M
2020	$1.9B	$359M	65.9%	20.7%	12.8%	6.1%	$325M	$1.9B	$598M
2019	$1.5B	-$41M	65.9%	-1.7%	-1.6%	-0.8%	$213M	$1.7B	$624M
2018	$1.5B	$190M	66.6%	17.8%	7.2%	3.3%	$250M	$2.2B	$1.2B
2017	$1.4B	$40M	65.1%	10.8%	1.6%	0.8%	$197M	$1.8B	$658M
2016	$1.3B	$80M	63.1%	7.4%	3.1%	1.9%	$267M	$1.1B	$439M
2015	—	$130M	—	—	5.1%	3.1%	$220M	$1.0B	$290M
2014	—	$116M	—	—	4.4%	2.6%	$201M	$1.2B	$393M
2013	—	$69M	—	—	2.5%	1.7%	$174M	$845M	$330M
2012	—	$130M	—	—	4.8%	3.2%	$143M	$847M	$394M
2011	—	$96M	—	—	3.8%	2.6%	$158M	$590M	$221M

Valuation over time

How the market has priced QGEN against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

The price-to-earnings ratio has risen from 23.5× (Mar '23) to 25.7× (Nov '26).
The price-to-sales ratio has risen from 4.6× (Mar '23) to 5.2× (Nov '26).
The dividend yield has fallen from 0.6% (Dec '25) to 0.5% (Nov '26).

Price / earnings (P/E)

P/E

Price / sales (P/S)

P/S

Dividend yield (%)

Dividend yield %

Frequently asked questions

Is QGEN growing its revenue and profit?

Over the past 5 years, Qiagen N.V.'s revenue has grown 2.2% per year, and net income grown 3.4% per year. These are computed facts, not advice.

How much debt does QGEN have?

As of FY2025, Qiagen N.V. reported $1.7B of total debt against $839M of cash; operating income covered interest expense 14×.

What is QGEN's profit margin?

In FY2025, gross margin was 62.2%, operating margin 22.3%, and net margin 20.3%.

What is QGEN's P/E ratio?

Qiagen N.V.'s P/E (TTM) is 25.70 as of the 2026-11-02 close — market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year, the same figure as on the QGEN stock page. The valuation chart above sets each month-end's price against the latest annual net income instead, so its latest point (about 25.7× as of Nov '26) can differ. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), split-adjusted; price return — dividends not reinvested · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.